UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
‘Obesity treatment will drastically change next few years’
An Irish expert on obesity and diabetes said Wednesday that prospects for t...
by Lee Han-soo
|
2019-12-04 18:20
라인
'Insulin is safe, natural replacement therapy for diabetic patients'
In Korea, 20.9 percent of diabetic patients, who have a hemoglobin A1c (HbA...
by Lee Han-soo
|
2019-12-04 17:07
라인
SK Biopharm set to ensure superiority in antiepileptic drug
SK Biopharmaceuticals said it would begin to develop a second new drug for ...
by Jeong Sae-im
|
2019-12-04 16:18
라인
Hanmi licenses in US firm’s oral immunotherapy candidate
Hanmi Pharmaceutical said that it has licensed in FLX475, the world’s first...
by Lee Han-soo
|
2019-12-04 16:16
라인
ISU Abxis starts trial of Gaucher disease treatment in Australia
ISU Abxis said that it has started phase 1 clinical trial of Abcertin, an e...
by Lee Han-soo
|
2019-12-04 16:16
라인
Samyang Biopharm’s US subsidiary to work on new immunotherapy
Samyang Biopharm USA said Tuesday it has signed a deal to adopt a new immun...
by Jeong Sae-im
|
2019-12-03 15:37
라인
Ildong signs co-promotion contract with GSK Consumer Healthcare
Ildong pharmaceutical said that it will co-promote GSK Consumer Healthcare’...
by Lee Han-soo
|
2019-12-03 15:18
라인
Global diabetes group opens 5-day show in Busan
The International Diabetes Federation (IDF) 2019 conference kicked off for ...
by Lee Han-soo
|
2019-12-03 11:04
라인
LG Chem licenses in US firm’s diagnostic platform tech
LG Chem said that it has licensed in a molecular diagnostic platform techno...
by Lee Han-soo
|
2019-12-02 13:42
라인
Syntekabio views industry’s crisis as opportunity
Syntekabio said that it aims to become the world's first publicly-trade...
by Jeong Sae-im
|
2019-11-29 17:54
라인
S. Biomedics to test embryonic stem cell-derived spinal cord injury treatment
S. Biomedics said that the Ministry of Food and Drug Safety has approved a ...
by Lee Han-soo
|
2019-11-29 15:42
라인
Daewoong challenges gastric acid blocker K-Cab with Fexuprazan
Daewoong Pharmaceutical said its new drug Fexuprazan will challenge the pot...
by Jeong Sae-im
|
2019-11-29 15:23
라인
Hanmi's Chinese partner to start trials for anticancer treatment
Hanmi Pharmaceutical said its Chinese partner Innovent Biologics has begun ...
by Lee Han-soo
|
2019-11-28 17:38
라인
GI Innovation licenses out immunotherapy drug candidate to Chinese firm
GI Innovation said that it has licensed out GI-101, a bispecific fusion pro...
by Lee Han-soo
|
2019-11-28 16:26
라인
Takeda's ovarian cancer drug Zejula to get insurance benefit
The government said it would grant insurance benefit to Takeda's ovaria...
by Lee Han-soo
|
2019-11-28 15:36
라인
ST Pharm submits IND application for colorectal cancer treatment in US
ST Pharm said that it has submitted an investigational new drug application...
by Lee Han-soo
|
2019-11-28 14:52
라인
New Parkinson’s drug Ongentys lands on Korea
SK Chemicals said Thursday it has won local marketing license for Ongentys ...
by Jeong Sae-im
|
2019-11-28 14:52
라인
Experts ascribe excessive diabetes hospitalization to lack of early treatment
Local diabetes experts on Wednesday stressed the need to treat diabetes at ...
by Lee Han-soo
|
2019-11-28 11:26
라인
Bristol-Myers Squibb Korea names new CEO
Bristol-Myers Squibb Korea said that it has appointed Kim Jin-young as the ...
by Lee Han-soo
|
2019-11-28 11:26
라인
SK Chemicals wins FDA nod for patch-type Alzheimer’s drug
SK Chemicals said it has obtained approval from the U.S. Food and Drug Admi...
by Jeong Sae-im
|
2019-11-27 18:24
-
이전
21
22
23
24
25
26
27
28
29
30
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top